By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Bristol-Myers Squibb Company 

345 Park Avenue

New York  New York  10154  U.S.A.
Phone: 212-546-4000 Fax: 212-546-4020


Key Statistics

Ownership: Public

Web Site: Bristol-Myers Squibb
Symbol: BMY



PanVera LLC 

Pharmagene Laboratories Limited 

Johnson & Johnson 

Amersham Biosciences 

Lexicon Genetics Incorporated 

Athersys  Athersys will provide Bristol-Myers Squibb with cell lines expressing validated drug targets produced using the RAGE-Validated Target technology. BMS plans to use its combinatorial chemistry capabilities to develop small molecule drug candidates against the validated targets.

Merck & Co.  Diabetes

Affinimark Technologies Inc. 

GlaxoSmithKline (North Carolina) 

Medarex, Inc. 

Gilead (Durham, NC) 

Phyton Biotech  - Cancer

Gilead (Seattle, WA) 

Company News
Janssen Biotech (JNJ) Announces Clinical Collaboration With Bristol-Myers Squibb (BMY) To Evaluate Immuno-Oncology Combination In Lung Cancer 7/26/2016 6:26:16 AM
Bristol-Myers Squibb (BMY) Appoints Fouad Namouni, M.D., Oncology Development Head 7/25/2016 9:36:28 AM
AbbVie (ABBV) Partners Up With Bristol-Myers Squibb (BMY) in Combo Treatment for Lung Cancer 7/25/2016 7:08:42 AM
Bristol-Myers Squibb (BMY) Announces Availability Of FDA-Approved ORENCIA (Abatacept) Clickject, A Self-Administered Subcutaneous Autoinjector, For Adults With Moderate To Severe Rheumatoid Arthritis 7/20/2016 10:54:05 AM
Why 5 Big Pharma’s Struggle to Please Investors 7/19/2016 6:48:09 AM
Bristol-Myers Squibb (BMY) Announces Regulatory Updates For Opdivo (Nivolumab) In Previously Treated Recurrent Or Metastatic Squamous Cell Carcinoma Of The Head And Neck 7/18/2016 9:47:02 AM
Bristol-Myers Squibb (BMY) Scoops Up Swedish Firm Cormorant in $520 Million Deal 7/5/2016 5:57:45 AM
PsiOxus Gets Upfront $10 Million, Ties Immuno-Oncology Clinical Pact With Bristol-Myers Squibb (BMY) 6/30/2016 6:35:36 AM
Bristol-Myers Squibb (BMY) Release: Sickle Cell Partnership Creates Demonstration Project To Treat Children In Angola 6/27/2016 11:14:17 AM
Bristol-Myers Squibb (BMY)'s Miracle Drug Opdivo Receives Yet Another Breakthrough Designation 6/27/2016 7:20:18 AM